Last updated: May 30, 2026
Prevalite is a cholestyramine resin product. The core “suppliers” for market access typically split into (1) the branded marketer/labeler and (2) the raw-material and resin manufacturers used to produce cholestyramine formulations. No reliable, complete supplier list can be produced without specific FDA labeler/distributor data and confirmed manufacturing-source disclosures.
Who supplies Prevalite in the US market?
Prevalite is sold in the US under the cholestyramine resin drug substance and delivered as a powder for oral suspension. In practice, the “supplier” question usually resolves to the FDA labeler (NDC label claim) and the contract manufacturing organization that produces the dosage form under that label.
What is the drug substance supplier chain for cholestyramine resin?
Cholestyramine is a crosslinked polymer (resin) used as an anion-exchange bile acid sequestrant. Supply inputs typically include:
- Crosslinkable polymer feedstocks used to build the resin matrix
- Quaternary amine functionalization inputs
- Purification and ionic form processing inputs
- Powdering, sifting, packaging, and stability-supporting excipients
How does labeling determine the “supplier” you should map?
For regulatory and commercial diligence, the most defensible “supplier” mapping is:
- FDA labeler / NDC holder
- Marketed dosage-form manufacturer listed on labeling and/or packaging
- Contract manufacturer and site(s) used for batch release (site-level mapping requires labeler manufacturing disclosure, not just brand name)
What generic or authorized alternatives supply the same active ingredient?
Prevalite’s active ingredient is cholestyramine resin. Competitive substitution risk and procurement choices are usually tied to:
- Other cholestyramine resin products marketed with different labelers
- Authorized generic supply arrangements (if any)
- Package-size differences that shift distributor ordering patterns
How does sourcing compare across cholestyramine resin products?
Supply continuity can vary by:
- Resin batch availability and polymer-to-resin conversion capacity
- Packaging format (scooped vs unit-dose)
- Particle size control and lot-to-lot consistency requirements
- Manufacturing site constraints and regulatory inspections
Which companies are typically involved in cholestyramine resin manufacturing?
Cholestyramine resin is produced by specialty API/resin manufacturers and then formulated/packaged by dosage-form facilities under contract or within the brand holder’s network. A complete company list for “Prevalite suppliers” requires confirming:
- The NDC labeler for each market package
- The manufacturing site(s) named on label or in FDA-related records
- Any distributor-only roles versus actual manufacturer roles
What are the procurement implications for distributors and hospitals?
Procurement teams typically reduce risk by:
- Diversifying labelers for the same active ingredient (cholestyramine resin)
- Establishing safety stock for each NDC/package size
- Validating lot release and stability data from the specific supplier chain for the purchased labeler
What triggers supply disruption risk?
For cholestyramine resin, supply pressure can be driven by:
- Polymer/resin feedstock availability
- Contract manufacturing capacity changes
- Packaging line constraints
- Quality system deviations tied to resin characteristics
What patent or exclusivity status affects supply?
Cholestyramine resin is an older, widely marketed active ingredient. For “supplier” mapping, patent status rarely blocks sourcing of the drug substance, but it can affect whether branded versions or specific formulations are competitively supplied without licensing. A complete patent and exclusivity landscape requires drug-specific regulatory exclusivity and Orange Book mapping that is not provided here.
Key Takeaways
- “Suppliers for Prevalite” typically means the FDA NDC labeler and the actual dosage-form manufacturer, plus the upstream resin makers for cholestyramine.
- A reliable, complete supplier roster cannot be produced from the single term “Prevalite” without labeler/NDC-to-manufacturer mapping and confirmed manufacturing-source disclosures.
FAQs
-
Is Prevalite a branded cholestyramine resin product or a generic?
Prevalite is a cholestyramine resin product marketed under a brand name; it shares its active ingredient with other cholestyramine resin products.
-
Who manufactures the cholestyramine resin used in Prevalite?
The resin is made by specialty API/resin manufacturers, but the specific supplier for Prevalite depends on confirmed labeler manufacturing sourcing.
-
Can hospitals substitute Prevalite with other cholestyramine resin products?
Yes, substitution is commonly possible at the active-ingredient level, subject to formularies and NDC/package requirements.
-
Does patent status block procurement of cholestyramine resin?
Typically, cholestyramine is not blocked by active exclusivity in a way that would prevent sourcing of the active ingredient, but exact constraints depend on labeler-specific rights.
-
What is the best way to identify the real supplier for a specific Prevalite NDC?
Use the NDC labeler and the manufacturer listed on the specific package labeling to map the dosage-form manufacturing site and distribution chain.
References
- FDA Orange Book (Drug Products). (Accessed via FDA Orange Book database).
- FDA Labeling and NDC directory resources. (Accessed via FDA databases).
